SMP201000095B - Inibitori di chinesina come terapeutici per il cancro - Google Patents

Inibitori di chinesina come terapeutici per il cancro

Info

Publication number: SMP201000095B
Authority: SM; San Marino
Prior art keywords: cancer therapies; kinesin inhibitors; kinesin; inhibitors; therapies
Prior art date: 2007-12-14

Application number

SM201000095T

Other languages

English (en)

Other versions

SMAP201000095A (it

Inventor

Paul A Renhowe

Paul Barsanti

Annette O Walter

David Duhl

Tinya Abrams

Michel Faure

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-14

Filing date

2010-07-13

Publication date

2011-09-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40328566&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMP201000095(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-07-13 Application filed by Novartis Ag filed Critical Novartis Ag

2010-09-10 Publication of SMAP201000095A publication Critical patent/SMAP201000095A/it

2011-09-09 Publication of SMP201000095B publication Critical patent/SMP201000095B/it

Links

102000010638 Kinesin Human genes 0.000 title 1
108010063296 Kinesin Proteins 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
238000011275 oncology therapy Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SM201000095T 2007-12-14 2010-07-13 Inibitori di chinesina come terapeutici per il cancro SMP201000095B (it)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1396607P	2007-12-14	2007-12-14
PCT/EP2008/067412 WO2009077448A1 (en)	2007-12-14	2008-12-12	Kinesin inhibitors as cancer therapeutics

Publications (2)

Publication Number	Publication Date
SMAP201000095A SMAP201000095A (it)	2010-09-10
SMP201000095B true SMP201000095B (it)	2011-09-09

Family

ID=40328566

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM201000095T SMP201000095B (it)	2007-12-14	2010-07-13	Inibitori di chinesina come terapeutici per il cancro

Country Status (30)

Country	Link
US (2)	US8252832B2 (it)
EP (1)	EP2229170B1 (it)
JP (1)	JP5501976B2 (it)
KR (1)	KR20100098394A (it)
CN (1)	CN101939005B (it)
AR (1)	AR069676A1 (it)
AU (1)	AU2008337570B2 (it)
BR (1)	BRPI0821248A2 (it)
CA (1)	CA2708822A1 (it)
CL (1)	CL2008003707A1 (it)
CO (1)	CO6290651A2 (it)
CR (1)	CR11412A (it)
DO (1)	DOP2010000175A (it)
EA (1)	EA018014B1 (it)
EC (1)	ECSP10010248A (it)
ES (1)	ES2459442T3 (it)
GE (1)	GEP20125647B (it)
GT (1)	GT201000172A (it)
IL (1)	IL205831A0 (it)
MA (1)	MA31872B1 (it)
MY (1)	MY150214A (it)
NI (1)	NI201000091A (it)
NZ (1)	NZ585142A (it)
PA (1)	PA8807801A1 (it)
PE (1)	PE20091451A1 (it)
SM (1)	SMP201000095B (it)
TN (1)	TN2010000204A1 (it)
TW (1)	TW200930704A (it)
UY (1)	UY31532A1 (it)
WO (1)	WO2009077448A1 (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8765817B1 (en)	2008-12-03	2014-07-01	Arrowhead Center, Inc.	Selective inhibitors of EG5 motors and methods of use
US8349899B1 (en)	2008-12-03	2013-01-08	Arrowhead Center, Inc.	Selective inhibitors of EG5 motors and methods of use
WO2011128388A2 (en) *	2010-04-15	2011-10-20	Novartis Ag	Oxazole and thiazole compounds as ksp inhibitors
EP2968591A1 (en) *	2013-03-15	2016-01-20	Novartis AG	Cell proliferation inhibitors and conjugates thereof
US9498540B2 (en)	2013-03-15	2016-11-22	Novartis Ag	Cell proliferation inhibitors and conjugates thereof
WO2016020791A1 (en)	2014-08-05	2016-02-11	Novartis Ag	Ckit antibody drug conjugates
SG11201710639YA (en) *	2015-06-22	2018-01-30	Bayer Pharma AG	Antibody drug conjugates (adcs) and antibody prodrug conjugates (apdcs) with enzymatically cleavable groups
CN105418527A (zh) *	2015-12-28	2016-03-23	青岛友诚高新技术有限公司	一种具有抗乳腺导管癌活性的化合物及其制备方法、用途
CN105646361B (zh) *	2016-02-17	2017-12-01	吉首大学	一种2,4,5‑三芳基咪唑型化合物及其制法和用途
AU2017380871C1 (en)	2016-12-21	2025-05-15	Bayer Aktiengesellschaft	Antibody drug conjugates (ADCs) having enzymatically cleavable groups
CN106668863B (zh) *	2017-02-21	2019-04-23	南方医科大学	靶向ktn1治疗皮肤鳞状细胞癌的药物
GB201706162D0 (en) *	2017-04-19	2017-05-31	Nat Univ Singapore	Compounds
CN111954532A (zh) *	2018-04-13	2020-11-17	上海交通大学医学院附属瑞金医院	杂芳基酰胺类化合物的抗肿瘤多药耐药性、治疗癌症的用途和蛋白质-药物分子复合物
CN109646679A (zh) *	2019-01-28	2019-04-19	中国科学院长春应用化学研究所	铁离子螯合剂及其可药用盐的用途
CN111529526B (zh) *	2020-04-14	2021-04-23	广州领晟医疗科技有限公司	一种化合物在制备治疗急性胰腺炎的药物中的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA06014909A (es) *	2004-06-18	2007-02-28	Chiron Corp	Derivados de n-(1-(1-bencil -4-fenil-1h -imidazol -2-il)-2, 2-dimetilpropil) benzamida y compuestos relacionados como inhibidores de proteina de huso de cinesina (ksp) para el tratamiento del cancer.
US7271271B2 (en)	2004-06-28	2007-09-18	Amgen Sf, Llc	Imidazolo-related compounds, compositions and methods for their use
MY147188A (en)	2005-08-09	2012-11-14	Novartis Ag	Substituted imidazole compounds as ksp inhibitors
GEP20125415B (en)	2007-01-05	2012-03-12	Novartis Ag	Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)

2008
- 2008-11-25 US US12/313,923 patent/US8252832B2/en not_active Expired - Fee Related
- 2008-12-12 PE PE2008002064A patent/PE20091451A1/es not_active Application Discontinuation
- 2008-12-12 TW TW097148535A patent/TW200930704A/zh unknown
- 2008-12-12 NZ NZ585142A patent/NZ585142A/en not_active IP Right Cessation
- 2008-12-12 MY MYPI2010002030A patent/MY150214A/en unknown
- 2008-12-12 EP EP08863009.0A patent/EP2229170B1/en active Active
- 2008-12-12 CA CA2708822A patent/CA2708822A1/en not_active Abandoned
- 2008-12-12 PA PA20088807801A patent/PA8807801A1/es unknown
- 2008-12-12 JP JP2010537460A patent/JP5501976B2/ja not_active Expired - Fee Related
- 2008-12-12 KR KR1020107012912A patent/KR20100098394A/ko not_active Withdrawn
- 2008-12-12 GE GEAP200811846A patent/GEP20125647B/en unknown
- 2008-12-12 ES ES08863009.0T patent/ES2459442T3/es active Active
- 2008-12-12 BR BRPI0821248-1A patent/BRPI0821248A2/pt not_active IP Right Cessation
- 2008-12-12 AR ARP080105410A patent/AR069676A1/es not_active Application Discontinuation
- 2008-12-12 WO PCT/EP2008/067412 patent/WO2009077448A1/en not_active Ceased
- 2008-12-12 CL CL2008003707A patent/CL2008003707A1/es unknown
- 2008-12-12 EA EA201000900A patent/EA018014B1/ru not_active IP Right Cessation
- 2008-12-12 AU AU2008337570A patent/AU2008337570B2/en not_active Ceased
- 2008-12-12 CN CN200880120667.8A patent/CN101939005B/zh not_active Expired - Fee Related
- 2008-12-15 UY UY31532A patent/UY31532A1/es not_active Application Discontinuation
2010
- 2010-05-05 CR CR11412A patent/CR11412A/es not_active Application Discontinuation
- 2010-05-07 TN TN2010000204A patent/TN2010000204A1/fr unknown
- 2010-05-17 IL IL205831A patent/IL205831A0/en unknown
- 2010-05-31 MA MA32879A patent/MA31872B1/fr unknown
- 2010-06-02 NI NI201000091A patent/NI201000091A/es unknown
- 2010-06-10 CO CO10070369A patent/CO6290651A2/es not_active Application Discontinuation
- 2010-06-11 DO DO2010000175A patent/DOP2010000175A/es unknown
- 2010-06-14 EC EC2010010248A patent/ECSP10010248A/es unknown
- 2010-06-14 GT GT201000172A patent/GT201000172A/es unknown
- 2010-07-13 SM SM201000095T patent/SMP201000095B/it unknown
2012
- 2012-07-11 US US13/546,713 patent/US8664256B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
TN2010000204A1 (en)	2011-11-11
UY31532A1 (es)	2009-08-03
CN101939005B (zh)	2015-12-16
AU2008337570B2 (en)	2012-04-05
CL2008003707A1 (es)	2009-06-05
WO2009077448A1 (en)	2009-06-25
EA018014B1 (ru)	2013-04-30
JP2011506402A (ja)	2011-03-03
EP2229170A1 (en)	2010-09-22
US20130012560A1 (en)	2013-01-10
US8664256B2 (en)	2014-03-04
ECSP10010248A (es)	2010-07-30
CR11412A (es)	2010-06-30
EA201000900A1 (ru)	2011-02-28
KR20100098394A (ko)	2010-09-06
CO6290651A2 (es)	2011-06-20
US20090239922A1 (en)	2009-09-24
AR069676A1 (es)	2010-02-10
TW200930704A (en)	2009-07-16
PA8807801A1 (es)	2009-07-23
AU2008337570A1 (en)	2009-06-25
SMAP201000095A (it)	2010-09-10
MY150214A (en)	2013-12-13
US8252832B2 (en)	2012-08-28
PE20091451A1 (es)	2009-10-19
JP5501976B2 (ja)	2014-05-28
MA31872B1 (fr)	2010-11-01
CN101939005A (zh)	2011-01-05
GEP20125647B (en)	2012-09-25
EP2229170B1 (en)	2014-01-22
ES2459442T3 (es)	2014-05-09
BRPI0821248A2 (pt)	2015-06-16
GT201000172A (es)	2012-04-30
NZ585142A (en)	2012-03-30
IL205831A0 (en)	2010-11-30
DOP2010000175A (es)	2010-06-30
CA2708822A1 (en)	2009-06-25
NI201000091A (es)	2011-03-15

Publication	Publication Date	Title
SMAP201000095A (it)	2010-09-10	Inibitori di chinesina come terapeutici per il cancro
CY2020023I2 (el)	2020-11-25	Αναστολεiς βητα-λακταμασων
CY2017016I1 (el)	2017-07-12	Αναστολεις πρωτεασωματος
SMAP200900085A (it)	2010-01-19	3-imidazolil-indoli per il trattamento di malattieproliferative
SMT201500043B (it)	2015-05-05	Indazoli ossazolo-sostituiti come inibitori di pi13-chinasi
SMT201600311B (it)	2016-11-10	Inibitori di cdk
SMT201500157B (it)	2015-09-07	Pirazolilaminopiridine come inibitori di fak
SMT201600104B (it)	2016-04-29	Inibitore di bromodominio benzodiazepinico
SMT201500271B (it)	2016-01-08	Inibitori di neprilisina
DK2041138T3 (da)	2014-08-11	Pyrroltriazinkinase-inhibitorer
DK2024375T3 (da)	2011-06-27	Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere
BRPI0810374A2 (pt)	2014-10-29	Inibidores específicos do pdgfrbeta
EP2263545A4 (en)	2011-05-04	sonographer
DK2124947T3 (da)	2017-11-06	Doseringsskema for comt-inhibitorer
ITVR20080024A1 (it)	2009-08-19	Struttura di tramoggia
BRPI0918564A2 (pt)	2015-12-01	inibidores
IL201367A0 (en)	2010-05-31	2 - morpholin - 4 - yl - pyrimidines as pi3k inhibitors
EP2283862A4 (en)	2012-09-26	CANCER AGENT
EP2189118A4 (en)	2013-10-23	ULTRASOUND DEVICE
SMT201700056B (it)	2017-03-08	Fosfaplatine e relativo utilizzo per il trattamento di cancro
DK2147122T3 (da)	2014-10-13	Enzymatisk kræftbehandling
EP2162436A4 (en)	2010-08-04	NEW CASE OF RENININHIBITORS
DK2066662T3 (da)	2013-01-07	Serinhydrolaseinhibitorer
EP2177529A4 (en)	2011-04-20	NEW SECRETASE HEMMER
SMT201500178B (it)	2015-09-07	Inibitori di nf-kb